The global Chitosan-based Hemostatic Gauze market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Chitosan-based Hemostatic Gauze competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Chitosan hemostatic gauze is a medical gauze made of natural polymer chitosan, which has excellent hemostatic properties and biocompatibility. Chitosan is a substance extracted from the shells of crustaceans that can promote platelet aggregation and blood clot formation, thereby accelerating the hemostasis process. This gauze is often used for wound treatment in trauma, surgery and emergency situations. It can not only stop bleeding quickly, but also reduce the risk of infection and promote wound healing.

The North American market for Chitosan-based Hemostatic Gauze is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Chitosan-based Hemostatic Gauze is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Chitosan-based Hemostatic Gauze include Anscare, Tricol Biomedical, Advamedica, Hemoflex, Mermaid Medical, BioPharm Med, MedTrade Products, Shijiazhuang Yishengtang Medical Product, Biotemed, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Chitosan-based Hemostatic Gauze market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Chitosan-based Hemostatic Gauze. The Chitosan-based Hemostatic Gauze market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Chitosan-based Hemostatic Gauze market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Chitosan-based Hemostatic Gauze manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Chitosan-based Hemostatic Gauze Market Report

Report Metric	Details
Report Name	Chitosan-based Hemostatic Gauze Market
Segment by Type	Z-shaped Folded Hemostatic Gauze Non-folded Hemostatic Gauze
by Application	Surgery First Aid
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Anscare, Tricol Biomedical, Advamedica, Hemoflex, Mermaid Medical, BioPharm Med, MedTrade Products, Shijiazhuang Yishengtang Medical Product, Biotemed
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Chitosan-based Hemostatic Gauze manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Chitosan-based Hemostatic Gauze sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Chitosan-based Hemostatic Gauze Market report?

Ans: The main players in the Chitosan-based Hemostatic Gauze Market are Anscare, Tricol Biomedical, Advamedica, Hemoflex, Mermaid Medical, BioPharm Med, MedTrade Products, Shijiazhuang Yishengtang Medical Product, Biotemed

What are the Application segmentation covered in the Chitosan-based Hemostatic Gauze Market report?

Ans: The Applications covered in the Chitosan-based Hemostatic Gauze Market report are Surgery, First Aid

What are the Type segmentation covered in the Chitosan-based Hemostatic Gauze Market report?

Ans: The Types covered in the Chitosan-based Hemostatic Gauze Market report are Z-shaped Folded Hemostatic Gauze, Non-folded Hemostatic Gauze

1 Chitosan-based Hemostatic Gauze Market Overview

1.1 Product Definition

1.2 Chitosan-based Hemostatic Gauze by Type

1.2.1 Global Chitosan-based Hemostatic Gauze Market Value by Type: 2025 vs 2032

1.2.2 Z-shaped Folded Hemostatic Gauze

1.2.3 Non-folded Hemostatic Gauze

1.3 Chitosan-based Hemostatic Gauze by Application

1.3.1 Global Chitosan-based Hemostatic Gauze Market Value by Application: 2025 vs 2032

1.3.2 Surgery

1.3.3 First Aid

1.4 Global Chitosan-based Hemostatic Gauze Market Size Estimates and Forecasts

1.4.1 Global Chitosan-based Hemostatic Gauze Revenue 2021–2032

1.4.2 Global Chitosan-based Hemostatic Gauze Sales 2021–2032

1.4.3 Global Chitosan-based Hemostatic Gauze Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Chitosan-based Hemostatic Gauze Market Competition by Manufacturers

2.1 Global Chitosan-based Hemostatic Gauze Sales Market Share by Manufacturers (2021–2026)

2.2 Global Chitosan-based Hemostatic Gauze Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Chitosan-based Hemostatic Gauze Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Chitosan-based Hemostatic Gauze, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Chitosan-based Hemostatic Gauze, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Chitosan-based Hemostatic Gauze, Product Types and Applications

2.7 Global Key Manufacturers of Chitosan-based Hemostatic Gauze, Date of Entry into the Industry

2.8 Global Chitosan-based Hemostatic Gauze Market Competitive Situation and Trends

2.8.1 Global Chitosan-based Hemostatic Gauze Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Chitosan-based Hemostatic Gauze Players Market Share by Revenue

2.8.3 Global Chitosan-based Hemostatic Gauze Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Chitosan-based Hemostatic Gauze Market Scenario by Region

3.1 Global Chitosan-based Hemostatic Gauze Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Chitosan-based Hemostatic Gauze Sales by Region: 2021–2032

3.2.1 Global Chitosan-based Hemostatic Gauze Sales by Region: 2021–2026

3.2.2 Global Chitosan-based Hemostatic Gauze Sales by Region: 2027–2032

3.3 Global Chitosan-based Hemostatic Gauze Revenue by Region: 2021–2032

3.3.1 Global Chitosan-based Hemostatic Gauze Revenue by Region: 2021–2026

3.3.2 Global Chitosan-based Hemostatic Gauze Revenue by Region: 2027–2032

3.4 North America Chitosan-based Hemostatic Gauze Market Facts & Figures by Country

3.4.1 North America Chitosan-based Hemostatic Gauze Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Chitosan-based Hemostatic Gauze Sales by Country (2021–2032)

3.4.3 North America Chitosan-based Hemostatic Gauze Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Chitosan-based Hemostatic Gauze Market Facts & Figures by Country

3.5.1 Europe Chitosan-based Hemostatic Gauze Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Chitosan-based Hemostatic Gauze Sales by Country (2021–2032)

3.5.3 Europe Chitosan-based Hemostatic Gauze Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Chitosan-based Hemostatic Gauze Market Facts & Figures by Region

3.6.1 Asia Pacific Chitosan-based Hemostatic Gauze Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Chitosan-based Hemostatic Gauze Sales by Region (2021–2032)

3.6.3 Asia Pacific Chitosan-based Hemostatic Gauze Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Chitosan-based Hemostatic Gauze Market Facts & Figures by Country

3.7.1 Latin America Chitosan-based Hemostatic Gauze Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Chitosan-based Hemostatic Gauze Sales by Country (2021–2032)

3.7.3 Latin America Chitosan-based Hemostatic Gauze Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Chitosan-based Hemostatic Gauze Market Facts & Figures by Country

3.8.1 Middle East and Africa Chitosan-based Hemostatic Gauze Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Chitosan-based Hemostatic Gauze Sales by Country (2021–2032)

3.8.3 Middle East and Africa Chitosan-based Hemostatic Gauze Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Chitosan-based Hemostatic Gauze Sales by Type (2021–2032)

4.1.1 Global Chitosan-based Hemostatic Gauze Sales by Type (2021–2026)

4.1.2 Global Chitosan-based Hemostatic Gauze Sales by Type (2027–2032)

4.1.3 Global Chitosan-based Hemostatic Gauze Sales Market Share by Type (2021–2032)

4.2 Global Chitosan-based Hemostatic Gauze Revenue by Type (2021–2032)

4.2.1 Global Chitosan-based Hemostatic Gauze Revenue by Type (2021–2026)

4.2.2 Global Chitosan-based Hemostatic Gauze Revenue by Type (2027–2032)

4.2.3 Global Chitosan-based Hemostatic Gauze Revenue Market Share by Type (2021–2032)

4.3 Global Chitosan-based Hemostatic Gauze Price by Type (2021–2032)

5 Segment by Application

5.1 Global Chitosan-based Hemostatic Gauze Sales by Application (2021–2032)

5.1.1 Global Chitosan-based Hemostatic Gauze Sales by Application (2021–2026)

5.1.2 Global Chitosan-based Hemostatic Gauze Sales by Application (2027–2032)

5.1.3 Global Chitosan-based Hemostatic Gauze Sales Market Share by Application (2021–2032)

5.2 Global Chitosan-based Hemostatic Gauze Revenue by Application (2021–2032)

5.2.1 Global Chitosan-based Hemostatic Gauze Revenue by Application (2021–2026)

5.2.2 Global Chitosan-based Hemostatic Gauze Revenue by Application (2027–2032)

5.2.3 Global Chitosan-based Hemostatic Gauze Revenue Market Share by Application (2021–2032)

5.3 Global Chitosan-based Hemostatic Gauze Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Anscare

6.1.1 Anscare Company Information

6.1.2 Anscare Description and Business Overview

6.1.3 Anscare Chitosan-based Hemostatic Gauze Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Anscare Chitosan-based Hemostatic Gauze Product Portfolio

6.1.5 Anscare Recent Developments/Updates

6.2 Tricol Biomedical

6.2.1 Tricol Biomedical Company Information

6.2.2 Tricol Biomedical Description and Business Overview

6.2.3 Tricol Biomedical Chitosan-based Hemostatic Gauze Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Tricol Biomedical Chitosan-based Hemostatic Gauze Product Portfolio

6.2.5 Tricol Biomedical Recent Developments/Updates

6.3 Advamedica

6.3.1 Advamedica Company Information

6.3.2 Advamedica Description and Business Overview

6.3.3 Advamedica Chitosan-based Hemostatic Gauze Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Advamedica Chitosan-based Hemostatic Gauze Product Portfolio

6.3.5 Advamedica Recent Developments/Updates

6.4 Hemoflex

6.4.1 Hemoflex Company Information

6.4.2 Hemoflex Description and Business Overview

6.4.3 Hemoflex Chitosan-based Hemostatic Gauze Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Hemoflex Chitosan-based Hemostatic Gauze Product Portfolio

6.4.5 Hemoflex Recent Developments/Updates

6.5 Mermaid Medical

6.5.1 Mermaid Medical Company Information

6.5.2 Mermaid Medical Description and Business Overview

6.5.3 Mermaid Medical Chitosan-based Hemostatic Gauze Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Mermaid Medical Chitosan-based Hemostatic Gauze Product Portfolio

6.5.5 Mermaid Medical Recent Developments/Updates

6.6 BioPharm Med

6.6.1 BioPharm Med Company Information

6.6.2 BioPharm Med Description and Business Overview

6.6.3 BioPharm Med Chitosan-based Hemostatic Gauze Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 BioPharm Med Chitosan-based Hemostatic Gauze Product Portfolio

6.6.5 BioPharm Med Recent Developments/Updates

6.7 MedTrade Products

6.7.1 MedTrade Products Company Information

6.7.2 MedTrade Products Description and Business Overview

6.7.3 MedTrade Products Chitosan-based Hemostatic Gauze Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 MedTrade Products Chitosan-based Hemostatic Gauze Product Portfolio

6.7.5 MedTrade Products Recent Developments/Updates

6.8 Shijiazhuang Yishengtang Medical Product

6.8.1 Shijiazhuang Yishengtang Medical Product Company Information

6.8.2 Shijiazhuang Yishengtang Medical Product Description and Business Overview

6.8.3 Shijiazhuang Yishengtang Medical Product Chitosan-based Hemostatic Gauze Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Shijiazhuang Yishengtang Medical Product Chitosan-based Hemostatic Gauze Product Portfolio

6.8.5 Shijiazhuang Yishengtang Medical Product Recent Developments/Updates

6.9 Biotemed

6.9.1 Biotemed Company Information

6.9.2 Biotemed Description and Business Overview

6.9.3 Biotemed Chitosan-based Hemostatic Gauze Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Biotemed Chitosan-based Hemostatic Gauze Product Portfolio

6.9.5 Biotemed Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Chitosan-based Hemostatic Gauze Industry Chain Analysis

7.2 Chitosan-based Hemostatic Gauze Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Chitosan-based Hemostatic Gauze Production Mode & Process Analysis

7.4 Chitosan-based Hemostatic Gauze Sales and Marketing

7.4.1 Chitosan-based Hemostatic Gauze Sales Channels

7.4.2 Chitosan-based Hemostatic Gauze Distributors

7.5 Chitosan-based Hemostatic Gauze Customer Analysis

8 Chitosan-based Hemostatic Gauze Market Dynamics

8.1 Chitosan-based Hemostatic Gauze Industry Trends

8.2 Chitosan-based Hemostatic Gauze Market Drivers

8.3 Chitosan-based Hemostatic Gauze Market Challenges

8.4 Chitosan-based Hemostatic Gauze Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Shijiazhuang Yishengtang Medical Product

Biotemed

BioPharm Med

List of Tables

Table 1. Global Chitosan-based Hemostatic Gauze Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Chitosan-based Hemostatic Gauze Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Chitosan-based Hemostatic Gauze Market Competitive Situation by Manufacturers in 2025

Table 4. Global Chitosan-based Hemostatic Gauze Sales (Units) of Key Manufacturers (2021–2026)

Table 5. Global Chitosan-based Hemostatic Gauze Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Chitosan-based Hemostatic Gauze Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Chitosan-based Hemostatic Gauze Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Chitosan-based Hemostatic Gauze Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Chitosan-based Hemostatic Gauze, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Chitosan-based Hemostatic Gauze, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Chitosan-based Hemostatic Gauze, Product Types and Applications

Table 12. Global Key Manufacturers of Chitosan-based Hemostatic Gauze, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Chitosan-based Hemostatic Gauze Companies by Tier (Tier 1, Tier 2, Tier 3), based on Chitosan-based Hemostatic Gauze Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Chitosan-based Hemostatic Gauze Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Chitosan-based Hemostatic Gauze Sales by Region (Units), 2021–2026

Table 18. Global Chitosan-based Hemostatic Gauze Sales Market Share by Region (2021–2026)

Table 19. Global Chitosan-based Hemostatic Gauze Sales by Region (Units), 2027–2032

Table 20. Global Chitosan-based Hemostatic Gauze Sales Market Share by Region (2027–2032)

Table 21. Global Chitosan-based Hemostatic Gauze Revenue by Region (US$ Million), 2021–2026

Table 22. Global Chitosan-based Hemostatic Gauze Revenue Market Share by Region (2021–2026)

Table 23. Global Chitosan-based Hemostatic Gauze Revenue by Region (US$ Million), 2027–2032

Table 24. Global Chitosan-based Hemostatic Gauze Revenue Market Share by Region (2027–2032)

Table 25. North America Chitosan-based Hemostatic Gauze Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Chitosan-based Hemostatic Gauze Sales by Country (Units), 2021–2026

Table 27. North America Chitosan-based Hemostatic Gauze Sales by Country (Units), 2027–2032

Table 28. North America Chitosan-based Hemostatic Gauze Revenue by Country (US$ Million), 2021–2026

Table 29. North America Chitosan-based Hemostatic Gauze Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Chitosan-based Hemostatic Gauze Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Chitosan-based Hemostatic Gauze Sales by Country (Units), 2021–2026

Table 32. Europe Chitosan-based Hemostatic Gauze Sales by Country (Units), 2027–2032

Table 33. Europe Chitosan-based Hemostatic Gauze Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Chitosan-based Hemostatic Gauze Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Chitosan-based Hemostatic Gauze Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Chitosan-based Hemostatic Gauze Sales by Region (Units), 2021–2026

Table 37. Asia Pacific Chitosan-based Hemostatic Gauze Sales by Region (Units), 2027–2032

Table 38. Asia Pacific Chitosan-based Hemostatic Gauze Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Chitosan-based Hemostatic Gauze Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Chitosan-based Hemostatic Gauze Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Chitosan-based Hemostatic Gauze Sales by Country (Units), 2021–2026

Table 42. Latin America Chitosan-based Hemostatic Gauze Sales by Country (Units), 2027–2032

Table 43. Latin America Chitosan-based Hemostatic Gauze Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Chitosan-based Hemostatic Gauze Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Chitosan-based Hemostatic Gauze Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Chitosan-based Hemostatic Gauze Sales by Country (Units), 2021–2026

Table 47. Middle East and Africa Chitosan-based Hemostatic Gauze Sales by Country (Units), 2027–2032

Table 48. Middle East and Africa Chitosan-based Hemostatic Gauze Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Chitosan-based Hemostatic Gauze Revenue by Country (US$ Million), 2027–2032

Table 50. Global Chitosan-based Hemostatic Gauze Sales (Units) by Type (2021–2026)

Table 51. Global Chitosan-based Hemostatic Gauze Sales (Units) by Type (2027–2032)

Table 52. Global Chitosan-based Hemostatic Gauze Sales Market Share by Type (2021–2026)

Table 53. Global Chitosan-based Hemostatic Gauze Sales Market Share by Type (2027–2032)

Table 54. Global Chitosan-based Hemostatic Gauze Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Chitosan-based Hemostatic Gauze Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Chitosan-based Hemostatic Gauze Revenue Market Share by Type (2021–2026)

Table 57. Global Chitosan-based Hemostatic Gauze Revenue Market Share by Type (2027–2032)

Table 58. Global Chitosan-based Hemostatic Gauze Price (US$/Unit) by Type (2021–2026)

Table 59. Global Chitosan-based Hemostatic Gauze Price (US$/Unit) by Type (2027–2032)

Table 60. Global Chitosan-based Hemostatic Gauze Sales (Units) by Application (2021–2026)

Table 61. Global Chitosan-based Hemostatic Gauze Sales (Units) by Application (2027–2032)

Table 62. Global Chitosan-based Hemostatic Gauze Sales Market Share by Application (2021–2026)

Table 63. Global Chitosan-based Hemostatic Gauze Sales Market Share by Application (2027–2032)

Table 64. Global Chitosan-based Hemostatic Gauze Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Chitosan-based Hemostatic Gauze Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Chitosan-based Hemostatic Gauze Revenue Market Share by Application (2021–2026)

Table 67. Global Chitosan-based Hemostatic Gauze Revenue Market Share by Application (2027–2032)

Table 68. Global Chitosan-based Hemostatic Gauze Price (US$/Unit) by Application (2021–2026)

Table 69. Global Chitosan-based Hemostatic Gauze Price (US$/Unit) by Application (2027–2032)

Table 70. Anscare Company Information

Table 71. Anscare Description and Business Overview

Table 72. Anscare Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. Anscare Chitosan-based Hemostatic Gauze Product

Table 74. Anscare Recent Developments/Updates

Table 75. Tricol Biomedical Company Information

Table 76. Tricol Biomedical Description and Business Overview

Table 77. Tricol Biomedical Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. Tricol Biomedical Chitosan-based Hemostatic Gauze Product

Table 79. Tricol Biomedical Recent Developments/Updates

Table 80. Advamedica Company Information

Table 81. Advamedica Description and Business Overview

Table 82. Advamedica Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 83. Advamedica Chitosan-based Hemostatic Gauze Product

Table 84. Advamedica Recent Developments/Updates

Table 85. Hemoflex Company Information

Table 86. Hemoflex Description and Business Overview

Table 87. Hemoflex Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 88. Hemoflex Chitosan-based Hemostatic Gauze Product

Table 89. Hemoflex Recent Developments/Updates

Table 90. Mermaid Medical Company Information

Table 91. Mermaid Medical Description and Business Overview

Table 92. Mermaid Medical Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 93. Mermaid Medical Chitosan-based Hemostatic Gauze Product

Table 94. Mermaid Medical Recent Developments/Updates

Table 95. BioPharm Med Company Information

Table 96. BioPharm Med Description and Business Overview

Table 97. BioPharm Med Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 98. BioPharm Med Chitosan-based Hemostatic Gauze Product

Table 99. BioPharm Med Recent Developments/Updates

Table 100. MedTrade Products Company Information

Table 101. MedTrade Products Description and Business Overview

Table 102. MedTrade Products Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 103. MedTrade Products Chitosan-based Hemostatic Gauze Product

Table 104. MedTrade Products Recent Developments/Updates

Table 105. Shijiazhuang Yishengtang Medical Product Company Information

Table 106. Shijiazhuang Yishengtang Medical Product Description and Business Overview

Table 107. Shijiazhuang Yishengtang Medical Product Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 108. Shijiazhuang Yishengtang Medical Product Chitosan-based Hemostatic Gauze Product

Table 109. Shijiazhuang Yishengtang Medical Product Recent Developments/Updates

Table 110. Biotemed Company Information

Table 111. Biotemed Description and Business Overview

Table 112. Biotemed Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 113. Biotemed Chitosan-based Hemostatic Gauze Product

Table 114. Biotemed Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Chitosan-based Hemostatic Gauze Distributors List

Table 118. Chitosan-based Hemostatic Gauze Customers List

Table 119. Chitosan-based Hemostatic Gauze Market Trends

Table 120. Chitosan-based Hemostatic Gauze Market Drivers

Table 121. Chitosan-based Hemostatic Gauze Market Challenges

Table 122. Chitosan-based Hemostatic Gauze Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Chitosan-based Hemostatic Gauze

Figure 2. Global Chitosan-based Hemostatic Gauze Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Chitosan-based Hemostatic Gauze Market Share by Type: 2025 & 2032

Figure 4. Z-shaped Folded Hemostatic Gauze Product Picture

Figure 5. Non-folded Hemostatic Gauze Product Picture

Figure 6. Global Chitosan-based Hemostatic Gauze Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Chitosan-based Hemostatic Gauze Market Share by Application: 2025 & 2032

Figure 8. Surgery

Figure 9. First Aid

Figure 10. Global Chitosan-based Hemostatic Gauze Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 11. Global Chitosan-based Hemostatic Gauze Market Size (US$ Million), 2021–2032

Figure 12. Global Chitosan-based Hemostatic Gauze Sales (Units), 2021–2032

Figure 13. Global Chitosan-based Hemostatic Gauze Average Price (US$/Unit), 2021–2032

Figure 14. Chitosan-based Hemostatic Gauze Report Years Considered

Figure 15. Chitosan-based Hemostatic Gauze Sales Share by Manufacturers in 2025

Figure 16. Global Chitosan-based Hemostatic Gauze Revenue Share by Manufacturers in 2025

Figure 17. Top 5 and Top 10 Global Chitosan-based Hemostatic Gauze Players: Market Share by Revenue in Chitosan-based Hemostatic Gauze in 2025

Figure 18. Chitosan-based Hemostatic Gauze Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 19. Global Chitosan-based Hemostatic Gauze Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 20. North America Chitosan-based Hemostatic Gauze Sales Market Share by Country (2021–2032)

Figure 21. North America Chitosan-based Hemostatic Gauze Revenue Market Share by Country (2021–2032)

Figure 22. United States Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 23. Canada Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 24. Europe Chitosan-based Hemostatic Gauze Sales Market Share by Country (2021–2032)

Figure 25. Europe Chitosan-based Hemostatic Gauze Revenue Market Share by Country (2021–2032)

Figure 26. Germany Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 27. France Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 28. U.K. Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. Italy Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Russia Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Asia Pacific Chitosan-based Hemostatic Gauze Sales Market Share by Region (2021–2032)

Figure 32. Asia Pacific Chitosan-based Hemostatic Gauze Revenue Market Share by Region (2021–2032)

Figure 33. China Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Japan Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. South Korea Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. India Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Australia Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. China Taiwan Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Southeast Asia Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Latin America Chitosan-based Hemostatic Gauze Sales Market Share by Country (2021–2032)

Figure 41. Latin America Chitosan-based Hemostatic Gauze Revenue Market Share by Country (2021–2032)

Figure 42. Mexico Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Brazil Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Argentina Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Colombia Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Middle East and Africa Chitosan-based Hemostatic Gauze Sales Market Share by Country (2021–2032)

Figure 47. Middle East and Africa Chitosan-based Hemostatic Gauze Revenue Market Share by Country (2021–2032)

Figure 48. Turkey Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Saudi Arabia Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. UAE Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Global Sales Market Share of Chitosan-based Hemostatic Gauze by Type (2021–2032)

Figure 52. Global Revenue Market Share of Chitosan-based Hemostatic Gauze by Type (2021–2032)

Figure 53. Global Chitosan-based Hemostatic Gauze Price (US$/Unit) by Type (2021–2032)

Figure 54. Global Sales Market Share of Chitosan-based Hemostatic Gauze by Application (2021–2032)

Figure 55. Global Revenue Market Share of Chitosan-based Hemostatic Gauze by Application (2021–2032)

Figure 56. Global Chitosan-based Hemostatic Gauze Price (US$/Unit) by Application (2021–2032)

Figure 57. Chitosan-based Hemostatic Gauze Value Chain

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions